H. Hara

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
H Hara, H. Hara, Hironori Hara
Publication record
102 papers · 1,654 citations · H-index 21

PAPERS

Who Is the True High-Bleeding-Risk Patient?
20250 citationsauthor #1
Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study.
20238 citationsauthor #18
Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization
20234 citationsauthor #3
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI.
202310 citationsauthor #29
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease
20226 citationsauthor #6
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022
2022106 citationsauthor #2
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.
202215 citationsauthor #3
Reply: Composite endpoints in clinical trials - simplicity or perfection?
20222 citationsauthor #1
Are We Unisex When Undergoing Left Main Revascularization?
20220 citationsauthor #3
Ten years survival benefit of CABG or PCI based on individual prediction
20220 citationsauthor #4
Mortality after multivessel revascularisation involving the proximal left anterior descending artery
20228 citationsauthor #2
Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization
202211 citationsauthor #6
Diagnostic concordance and discordance between angiography-based quantitative flow ratio and fractional flow reserve derived from computed tomography in complex coronary artery disease.
202217 citationsauthor #4
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
202210 citationsauthor #4
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.
202227 citationsauthor #2
Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
202211 citationsauthor #1
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience
20225 citationsauthor #4
TCT-83 A Comparison Between CEC-Based and QFR-Based Adjudication Among 3,457 Patients From 4 Randomized Controlled Trials
20210 citationsauthor #3
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
202147 citationsauthor #4
TCT-109 Ten-Year All-Cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease
20211 citationsauthor #3
A comparison of risk prediction models for patients with acute coronary syndromes.
20210 citationsauthor #1
10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
202153 citationsauthor #3
TCT-492 External Validation of the SYNTAX Score II 2020 in the CREDO-Kyoto PCI/CABG Registry
20210 citationsauthor #1
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial.
20215 citationsauthor #1
TCT-493 Impact of Established Cardiovascular Disease on 10-Year Death After Coronary Revascularization for Complex Coronary Artery Disease
20210 citationsauthor #6
Current perspectives on bioresorbable scaffolds in coronary intervention and other fields
202121 citationsauthor #4
TCT-304 Ten-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification
20211 citationsauthor #3
Impact of stent length and diameter on 10‐year mortality in the SYNTAXES trial
202117 citationsauthor #1
Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial).
202110 citationsauthor #3
TCT-279 Impact of Body Composition Indices on Ten-Year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial)
20210 citationsauthor #3
Long-term prediction of mortality and comparative treatment benefit following percutaneous or surgical revascularization
20210 citationsauthor #1
Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study
202117 citationsauthor #6
Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials
20215 citationsauthor #3
TCT-13 Ten-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease
20210 citationsauthor #3
TCT-113 Ten-Year Survival Benefit and Appropriateness of Surgical or Percutaneous Revascularization Based on Individual Predicted All-Cause Mortality in Patients With Complex Coronary Artery Disease
20210 citationsauthor #4
Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond
20213 citationsauthor #5
Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease: JACC State-of-the-Art Review.
2021157 citationsauthor #2
Ten-year all-cause mortality following staged percutaneous revascularization in patients with complex coronary artery disease.
20212 citationsauthor #3
Trade-Off Between Bleeding and Thrombotic Risk in Patients With Academic Research Consortium for High Bleeding Risk.
20216 citationsauthor #1
TCT-201 Impact of Proton Pump Inhibitors on Efficacy of Antiplatelet Strategies With Ticagrelor or Aspirin After Percutaneous Coronary Intervention
20210 citationsauthor #4
Coronary interventions 2020: the year in review.
20211 citationsauthor #3
Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
2021100 citationsauthor #22
‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial
20219 citationsauthor #2
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease
202141 citationsauthor #4
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.
202161 citationsauthor #3
Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease
202125 citationsauthor #5
Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease
20217 citationsauthor #6
TCT-244 Impact of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization
20210 citationsauthor #6
Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.
202129 citationsauthor #4
External validation of the GRACE risk score 2.0 in the contemporary all‐comers GLOBAL LEADERS trial
20213 citationsauthor #3
Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
202126 citationsauthor #4
Have We Overdefined Periprocedural Myocardial Infarction to the Point of Extinction?
20217 citationsauthor #2
TCT-112 Repeat Revascularization Impact on 10-Year Survival After PCI or CABG: Post Hoc Analysis of the SYNTAXES Trial
20210 citationsauthor #3
External Validation of the SYNTAX Score II 2020.
202140 citationsauthor #1
A Prospective Multicenter Validation Study for A Novel Angiography-derived Physiological Assessment Software: Rationale and Design of the Radiographic imaging Validation and EvALuation for Angio-iFR (ReVEAL iFR) study.
20219 citationsauthor #10
TCT-473 Impact of Major Infections on 10-Year Mortality After Revascularization in Patients With Complex Coronary Artery Disease
20210 citationsauthor #3
Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
20213 citationsauthor #3
Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial
202019 citationsauthor #9
Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging
202099 citationsauthor #3
Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update
20209 citationsauthor #6
The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial.
20203 citationsauthor #10
The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEX.
202011 citationsauthor #8
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
202021 citationsauthor #8
Ten-year all-cause death after percutaneous or surgical revascularization for men and women with multivessel or left main coronary artery disease: insights from the SYNTAX extended survival study
20200 citationsauthor #1
The state-of-the-art coronary stent with crystallized sirolimus: the MiStent technology and its clinical program.
20204 citationsauthor #6
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
202019 citationsauthor #6
Did the SYNTAX Score Pass the Test of Time?
20204 citationsauthor #2
Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial
20205 citationsauthor #1
A randomized controlled trial to compare the safety and efficacy of sirolimus-eluting biodegradable polymer ultra-thin stent (SUPRAFLEX Cruz) and everolimus-eluting biodegradable polymer stent (SYNERGY) in treatment for three-vessel coronary artery disease: design of the Multivessel TALENT trial.
20203 citationsauthor #1
Impact of the CABG SYNTAX Score on 10-year All-cause Death: Insights from the SYNTAX Extended Survival Study.
20203 citationsauthor #3
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial.
20205 citationsauthor #7
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).
20205 citationsauthor #5
A prospective multicenter randomized trial to assess the effectiveness of the magic touch sirolimus-coated balloon in small vessels: Rationale and design of the TRANSFORM I trial.
202023 citationsauthor #3
Impact of periprocedural myocardial infarction on 10-year mortality after percutaneous coronary intervention or coronary artery bypass grafting for multivessel or left main coronary artery disease
20200 citationsauthor #1
Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction
20203 citationsauthor #2
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study.
202095 citationsauthor #9
Regional variation in patients and outcomes in the GLOBAL LEADERS trial.
20205 citationsauthor #4
Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.
202045 citationsauthor #1
Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
202093 citationsauthor #1
Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention
202019 citationsauthor #1
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.
20207 citationsauthor #14
The year in review: coronary interventions
20201 citationsauthor #6
Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events
202017 citationsauthor #6
Impact of White Blood Cell Count on Clinical Outcomes in Patients Treated with Aspirin-Free Ticagrelor Monotherapy after Percutaneous Coronary Intervention: Insights from the GLOBAL LEADERS Trial.
202012 citationsauthor #8
Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.
202033 citationsauthor #5
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events
202010 citationsauthor #1
The Impact of Coronary Physiology on Contemporary Clinical Decision Making.
202090 citationsauthor #5
Ten-year all-cause death in elderly patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: a prespecified subgroup analysis of the SYNTAX Extended Survival study
20200 citationsauthor #3
The "A, B, C" of multiple statistical methods for composite endpoints.
202013 citationsauthor #1
Signet ring-like appearance: specific feature of vulnerable plaques detected by 320-slice multidetector computed tomography.
20140 citationsauthor #1
Incidence and predictors for late target lesion revascularization after sirolimus-eluting stent implantation.
201312 citationsauthor #1
Aortic regurgitation due to back-and-forth intimal flap movement detected by both multidetector computed tomography and transesophageal echocardiography.
20132 citationsauthor #1
Impact of the Clinical Syntax Score on 5-year clinical outcomes after sirolimus-eluting stents implantation
20138 citationsauthor #1
ACCURACY OF 320-DETECTOR ROW COMPUTED TOMOGRAPHY TO IDENTIFY SIGNIFICANT CORONARY STENOSES IN PATIENTS WITH ATRIAL FIBRILLATION
20123 citationsauthor #9
IMPACT OF?3/6 POLYUNSATURATED FATTY ACIDS RATIO ON THE PREVALENCE OF CORONARY ARTERY DISEASE ASSESSED BY 320-ROW CT CORONARY ANGIOGRAPHY
20121 citationsauthor #7
Abstract 15743: The Clinical Syntax Score Is A Predictor Of 5-year Clinical Outcomes After Sirolimus-eluting Stents Implantation Amongst All-comers Population
20110 citationsauthor #1
Differential Diagnosis of Gallbladder Polypoid Lesions Assessed with Contrast-Enhanced Ultrasonography
20110 citationsauthor #7
Abstract 14798: Predictors Of Late Target Lesion Revascularization After Sirolimus-eluting Stent Implantation
20110 citationsauthor #1
Abstract 13206: Impact of Substantial 5-Year Dual Antiplatelet Therapy After Sirolimus-Eluting Stents Implantation
20110 citationsauthor #1
Mid-term follow-up of coronary artery aneurysm after directional coronary atherectomy.
19992 citationsauthor #6

TIMELINE

1995 9 citations

1996 2 citations

1999 2 citations

2011 0 citations

2012 4 citations

2013 22 citations

2014 0 citations

2020 676 citations

2021 706 citations

2022 218 citations

2023 22 citations

2025 0 citations

H. Hara

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT